Picture of Canopy Growth logo

CGC Canopy Growth News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Cannabis stocks rise on report saying Trump may ease curbs this week

Updates

** U.S.-listed shares of cannabis companies extend gains after CNN reports that President Donald Trump is expected to sign an executive order on easing restrictions on the Schedule I narcotic and deem it a less dangerous drug on Thursday

** Shares of Cronos Group CRON.TO CRON.O, and Aurora Cannabis ACB.TO,  rise 2.8% and 2%

** Tilray Brands TLRY.TO, TLRY.O up 5%, and Canopy Growth WEED.TO, CGC.O jump 15%

** Stocks have soared since reports last week emerged of Trump's plan to ease the curbs

** Under current federal law, marijuana remains a Schedule I controlled substance, which are substances with no currently accepted medical use and a high potential for abuse, alongside LSD and heroin, despite state-level medical legalization in places like California

** A reclassification could ease criminal penalties and reshape the pot industry by lowering tax burdens and making it easier for firms to secure funding

 (Reporting by Padmanabhan Ananthan in Bengaluru)

 ((Padmanabhan.Ananthan@thomsonreuters.com))

Recent news on Canopy Growth

See all news